Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02340975 |
|---|---|
| Brief Title: | A Phase 1b/2 Study of MEDI4736 With Tremelimumab, MEDI4736 or Tremelimumab Monotherapy in Gastric or GEJ Adenocarcinoma |
| First Submitted : | January 14, 2015 |
| First Submitted that Met QC Criteria : | January 14, 2015 |
| First Posted : | January 19, 2015 (Estimate) |
| Results First Submitted : | April 27, 2020 |
| Results First Submitted that Met QC Criteria : | April 27, 2020 |
| Results First Posted : | May 11, 2020 |
| Last Update Submitted that Met QC Criteria : | June 2, 2020 |
| Last Update Posted : | June 9, 2020 |